Cardiovascular Journal of Africa: Vol 21 No 2 (March/April 2010) - page 23

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 21, No 2, March/April 2010 AFRICA 85
References
Levy D, Garrison RJ, Savage DD, 1. et al. Prognostic implications
of echocardiographically determined left ventricular mass in the
Framingham Heart study. N Engl J Med 1990; 322: 1561.
Verdecchia P, Schillaci G, Borgioni C, 2. et al. Prognostic value of a new
electrocardiographic method for diagnosis of left ventricular hypertro-
phy in essential hypertension. J Am Coll Cardiol 1998; 31(2): 383–390.
Levy D. Clinical significance of left ventricular hypertrophy: insights 3.
from the Framingham study. J Cardiovasc Pharmacol 1991; 17(Suppl
2): S1–6.
Levy D, Salomon M, D’Agostino RB, Belanger AJ, Kannel WB. 4.
Prognostic implications of baseline electrocardiographic features and
their serial changes in subjects with left ventricular hypertrophy.
Circulation 1994; 90(4): 1786–1793.
Galderisi M, Lauer MS, Levy D. Echocardiographic determinants 5.
of clinical outcome in subjects with coronary artery disease (the
Framingham Heart Study). Am J Cardiol 1992; 70(11): 971–976.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left 6.
ventricular mass and incidence of coronary heart disease in an elderly
cohort. The Framingham Heart study. Ann Intern Med 1989; 110(2):
101–107.
Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli 7.
WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the
Framingham Heart Study. Am J Cardiol 1987; 60(7): 560–565.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic 8.
implications of echocardiographically determined left ventricular mass
in the Framingham Heart study. N Engl J Med 1990; 322(22): 1561–
1566.
Verdecchia P, Schillaci G, Borgioni C, 9. et al. Prognostic value of left
ventricular mass and geometry in systemic hypertension with left
ventricular hypertrophy. Am J Cardiol 1996; 78(2): 197–202.
Dahlof B, Devereux RB, Kjeldsen SE, 10. et al. Cardiovascular morbidity
and mortality in the Losartan Intervention For Endpoint reduction in
hypertension study (LIFE): a randomised trial against atenolol. Lancet
2002; 359(9311): 995–1003.
Kjeldsen SE, Dahlof B, Devereux RB, 11. et al. Lowering of blood pressure
and predictors of response in patients with left ventricular hypertrophy:
the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens
2000; 13(8): 899–906.
Wachtell K, Olsen MH, Dahlof B, 12. et al. Microalbuminuria in hyperten-
sive patients with electrocardiographic left ventricular hypertrophy: the
LIFE study. J Hypertens 2002; 20(3): 405–412.
The Seventh Report of the Joint National Committee on Prevention, 13.
Detection, Evaluation, and Treatment of High Blood Pressure (The JNC
7 Report). J Am Med Assoc 2003; 289(19): 2560–2572.
Adebiyi AA, Ogah OS, Aje A, 14. et al. Echocardiographic partition values
and prevalence of left ventricular hypertrophy in hypertensive Nigerians.
BMC Med Imaging 2006; 6: 10.
Du Bois D, Du Bois E. A formula to estimate the approximate surface 15.
area if height and weight be known. Arch Intern Med 1916; 17:
863–867.
Devereux RB, Alonso DR, Lutas EM, 16. et al . Echocardiographic assess-
ment of left ventricular hypertrophy: comparison to necropsy findings.
Am J Cardiol 1986; 57: 450–458.
Adebiyi AA, AJE A, Ogah OS, 17. et al. Correlates of left atrial size in
Nigerian hypertensives. Cardiovasc J South Afr 2005; 16(3): 201–204.
Devereux RB, E.M L, Casale PN, 18. et al. Standardization of M-Mode
echocardiographic left ventricular anatomic measurements. J Am Coll
Cardiol 1984; 4: 1222.
Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. 19.
Association of carotid atherosclerosis and left ventricular hypertrophy.
J Am Coll Cardiol 1995; 25(1): 83–90.
Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocar- 20.
diographic volume determination: echocardiographic–angiographic
correlations in the presence of absence of asynergy. Am J Cardiol 1976;
37: 7–11.
Devereux RB, Roman MJ, Paranicas M, 21. et al. Relation of Doppler stroke
distance and aortic annular diameter to left ventricular stroke volume
in normotensive and hypertensive American Indians: the strong Heart
study. Am J Hypertens 1997; 10: 619–628.
Ferguson JJ, Julius S, Randall OS. Stroke volume:pulse pressure rela- 22.
tionships in borderline hypertension: a possible indicator of decreased
arterial compliance. J Hypertens 1984; 2(Suppl 3): 397–399.
Randall OS, Westerhof N, VanDen Bos GC, Alexander B. Reliability of 23.
stroke volume to pulse pressure ratio for estimating and detecting chang-
es in arterial compliance. J Hypertens 1986; 4(Suppl 5): S293–S296.
Liebson PR, Granditis G, Prineas R, 24. et al. Echocardiographic corre-
lates of left ventricular structure among 844 mildly hypertensive men
and women in the Treatment Of Mild Hypertension Study (TOHMS).
Circulation 1993; 87: 476.
Tingleff J, Munch M, Jakobsen TJ, et al. Prevalence of left ventricular 25.
hypertrophy in a hypertensive population. Eur Heart J 1996; 17(1):
143–149.
Tingleff J, Munch M, Jakobsen TJ, 26. et al. [Prevalence of left ventricular
hypertrophy in Danish patients with hypertension]. Ugeskr Laeger 1997;
159(37): 5529–5533.
Ganau A, Devereux RB, Roman MJ, 27. et al. Patterns of left ventricular
hypertrophy and geometric remodeling in essential hypertension. J Am
Coll Cardiol 1992; 19(7): 1550–1558.
Ganau A, Saba PS, Roman MJ, de Simone G, Realdi G, Devereux RB. 28.
Ageing induces left ventricular concentric remodelling in normotensive
subjects. J Hypertens 1995; 13(12 Pt 2): 1818–1822.
Jones EC, Devereaux RB, O’Grady MJ, 29. et al. Relation of haemo-
dynamic load to arterial and cardiac size. J Am Coll Cardiol 1997;
29:1303–1310.
Dahan M, Siohan P, Viron B, 30. et al. Relationship between Left ventricular
hypertrophy, myocardial contractility, and load conditions in haemodi-
alysis patients: an echocardiographic study. Am J Kidney Dis 1997; 30:
780–785.
Chen C, Ting C, Lin S, 31. et al. Which arterial and cardiac parameters best
predict left ventricular mass? Circulation 1998; 98: 422–428.
Lakatta EG. Similar myocardial effects of aging and hypertension. 32. Eur
Heart J 1990; 11(Suppl G): 29–38.
Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. Relation 33.
of alcohol intake to left ventricular mass: The Framingham Study. J Am
Coll Cardiol 1991; 17(3): 717–721.
Sax FL, Brush JE, Cannon RO, 34. et al. Impaired left ventricular fill-
ing in symptomatic compared to asymptomatic hypertensive patients
(abstract). J Am Coll Cardiol 1988; 11: 81A.
Schunkert H. Obesity and target organ damage: the heart. 35. Int J Obes
Relat Metab Disord 2002; 26(Suppl 4): S15–20.
Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of 36.
left ventricular mass:The Framingham Heart study. Hypertension 1997;
30: 1025–1028.
Messerli FH. 37. Clinical Determinants and Manifestations of Left
Ventricular Hypertrophy. NewYork: Yorke Medical Books, 1987.
Rasooly Y, Sasson Z, Gupta R. Relation between body fat distribution 38.
and left ventricular mass in men without structural heart disease or
systemic hypertension. Am J Cardiol 1993; 71: 1477.
Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardio- 39.
graphic left ventricular mass in a healthy population (the Framingham
study). Am J Cardiol 1989; 64: 1066.
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius 40.
S. Sex-specific determinants of increased left ventricular mass in the
Tecumseh Blood Pressure Study. Circulation 1994; 90(2): 928–936.
Koenig H, Goldstone A, Lu CY. Testosterone-medicated sexual dimor- 41.
phism in the rodent heart: Ventricular lysosomes, mitochondria, and cell
growth are modulated by androgens. Circ Res 1982; 50: 782.
Devereaux RB. Towards a more understanding of left ventricular after- 42.
load. J Am Coll Cardiol 1991; 17: 122–124.